Loading clinical trials...

Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT01466361

Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving

This study is designed to evaluate the ability of a nicotine lozenge to relieve craving for a cigarette compared to a matched placebo (a placebo is like sugar pill and contains no active).

Lead sponsor: GlaxoSmithKline•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Cigarette Filter Study

NCT07348679 · Smoking ( Cigarette)

RECRUITINGPhase 2

Cannabidiol for Reducing Cigarette Use

NCT06218056 · Tobacco Use Disorder, Tobacco Smoking, and more

RECRUITINGPhase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation

RECRUITINGNA

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

NCT06372899 · E-cigarette Use, Cigarette Smoking, and more

RECRUITINGNA

Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients

NCT07441928 · Smoking Cessation, Schizophenia Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 28, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment187

Start dateSep 2010

Last updatedAug 28, 2019

Condition

Smoking Smoking Cessation

Locations shown

Los Angeles Clinical Trials

Burbank, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2019Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Cigarette Filter Study

Cannabidiol for Reducing Cigarette Use

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients

Trial snapshot

Condition

Locations shown

For caregivers